<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">24625757</PMID>
        <DateCompleted>
            <Year>2016</Year>
            <Month>01</Month>
            <Day>25</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>11</Month>
            <Day>13</Day>
        </DateRevised>
        <Article PubModel="Electronic-eCollection">
            <Journal>
                <ISSN IssnType="Electronic">1932-6203</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>9</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2014</Year>
                    </PubDate>
                </JournalIssue>
                <Title>PloS one</Title>
                <ISOAbbreviation>PLoS One</ISOAbbreviation>
            </Journal>
            <ArticleTitle>HPV E6/E7 RNA in situ hybridization signal patterns as biomarkers of three-tier cervical intraepithelial neoplasia grade.</ArticleTitle>
            <Pagination>
                <MedlinePgn>e91142</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0091142</ELocationID>
            <Abstract>
                <AbstractText>Cervical lesion grading is critical for effective patient management. A three-tier classification (cervical intraepithelial neoplasia [CIN] grade 1, 2 or 3) based on H&amp;E slide review is widely used. However, for reasons of considerable inter-observer variation in CIN grade assignment and for want of a biomarker validating a three-fold stratification, CAP-ASCCP LAST consensus guidelines recommend a two-tier system: low- or high-grade squamous intraepithelial lesions (LSIL or HSIL). In this study, high-risk HPV E6/E7 and p16 mRNA expression patterns in eighty-six CIN lesions were investigated by RNAscope chromogenic in situ hybridization (CISH). Specimens were also screened by immunohistochemistry for p16INK4a (clone E6H4), and by tyramide-based CISH for HPV DNA. HPV genotyping was performed by GP5+/6+ PCR combined with cycle-sequencing. Abundant high-risk HPV RNA CISH signals were detected in 26/32 (81.3%) CIN 1, 22/22 (100%) CIN 2 and in 32/32 (100%) CIN 3 lesions. CIN 1 staining patterns were typified (67.7% specimens) by abundant diffusely staining nuclei in the upper epithelial layers; CIN 2 lesions mostly (66.7%) showed a combination of superficial diffuse-stained nuclei and multiple dot-like nuclear and cytoplasmic signals throughout the epithelium; CIN 3 lesions were characterized (87.5%) by multiple dot-like nuclear and cytoplasmic signals throughout the epithelial thickness and absence/scarcity of diffusely staining nuclei (trend across CIN grades: P&lt;0.0001). These data are consistent with productive phase HPV infections exemplifying CIN 1, transformative phase infections CIN 3, whereas CIN 2 shows both productive and transformative phase elements. Three-tier data correlation was not found for the other assays examined. The dual discernment of diffuse and/or dot-like signals together with the assay's high sensitivity for HPV support the use of HPV E6/E7 RNA CISH as an adjunct test for deciding lesion grade when CIN 2 grading may be beneficial (e.g. among young women) or when 'LSIL vs. HSIL' assignment is equivocal. </AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Evans</LastName>
                    <ForeName>Mark F</ForeName>
                    <Initials>MF</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, University of Vermont, Burlington, Vermont, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Peng</LastName>
                    <ForeName>Zhihua</ForeName>
                    <Initials>Z</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, University of Vermont, Burlington, Vermont, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Clark</LastName>
                    <ForeName>Kelli M</ForeName>
                    <Initials>KM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, University of Vermont, Burlington, Vermont, United States of America; Department of Pathology and Laboratory Medicine, Fletcher Allen Health Care, Burlington, Vermont, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Adamson</LastName>
                    <ForeName>Christine S-C</ForeName>
                    <Initials>CS</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, University of Vermont, Burlington, Vermont, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Xiao-Jun</ForeName>
                    <Initials>XJ</Initials>
                    <AffiliationInfo>
                        <Affiliation>Advanced Cell Diagnostics, Inc., Hayward, California, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Xingyong</ForeName>
                    <Initials>X</Initials>
                    <AffiliationInfo>
                        <Affiliation>Advanced Cell Diagnostics, Inc., Hayward, California, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Hongwei</ForeName>
                    <Initials>H</Initials>
                    <AffiliationInfo>
                        <Affiliation>Advanced Cell Diagnostics, Inc., Hayward, California, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Luo</LastName>
                    <ForeName>Yuling</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>Advanced Cell Diagnostics, Inc., Hayward, California, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cooper</LastName>
                    <ForeName>Kumarasen</ForeName>
                    <Initials>K</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Pathology, University of Vermont, Burlington, Vermont, United States of America; Department of Pathology and Laboratory Medicine, Fletcher Allen Health Care, Burlington, Vermont, United States of America.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>03</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>PLoS One</MedlineTA>
            <NlmUniqueID>101285081</NlmUniqueID>
            <ISSNLinking>1932-6203</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D019941">Cyclin-Dependent Kinase Inhibitor p16</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C052603">E6 protein, Human papillomavirus type 18</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="C052633">E7 protein, Human papillomavirus type 18</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D009856">Oncogene Proteins, Viral</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018290" MajorTopicYN="N">Cervical Intraepithelial Neoplasia</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D019941" MajorTopicYN="N">Cyclin-Dependent Kinase Inhibitor p16</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005814" MajorTopicYN="N">Genes, Viral</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D017403" MajorTopicYN="N">In Situ Hybridization</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009856" MajorTopicYN="N">Oncogene Proteins, Viral</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D027383" MajorTopicYN="N">Papillomaviridae</DescriptorName>
                <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D030361" MajorTopicYN="N">Papillomavirus Infections</DescriptorName>
                <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
                <QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>02</Month>
                <Day>07</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2016</Year>
                <Month>1</Month>
                <Day>26</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>epublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">24625757</ArticleId>
            <ArticleId IdType="doi">10.1371/journal.pone.0091142</ArticleId>
            <ArticleId IdType="pii">PONE-D-13-52688</ArticleId>
            <ArticleId IdType="pmc">PMC3953338</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Mod Pathol. 2002 Dec;15(12):1339-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12481016</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 1992 Aug;73 ( Pt 8):2047-57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1322961</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Pathol. 1991 May;44(5):400-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1646237</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Dis Markers. 2007;23(4):297-313</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17627064</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Gynecol Oncol. 2009 Jan;112(1):114-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19007972</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Virology. 1992 Jul;189(1):132-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1318602</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Obstet Gynecol. 2010 Dec;116(6):1373-80</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21099605</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Vaccine. 2012 Nov 20;30 Suppl 5:F55-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23199966</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Gynecol Pathol. 2013 Jan;32(1):76-115</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23202792</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Obstet Gynecol. 2011 Nov;205(5):478.e1-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21872201</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Sci (Lond). 2006 May;110(5):525-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16597322</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 1991 Apr;72 ( Pt 4):885-95</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1849971</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Natl Cancer Inst. 2001 Feb 21;93(4):293-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11181776</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Obstet Gynecol. 2012 Dec;120(6):1465-71</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23168774</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1991 Aug 1;68(3):561-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1648434</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Arch Med Res. 2009 Aug;40(6):435-42</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19853183</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gen Virol. 1992 Jul;73 ( Pt 7):1833-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1321217</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer. 1992 Jul 1;70(1):136-46</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1318774</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Obstet Gynecol. 2009 Dec;114(6):1232-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">19935024</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Gynaecol Oncol. 2012;33(1):5-14</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22439398</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Pathol. 1992 Feb;23(2):117-28</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">1310950</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Br J Cancer. 1995 Aug;72(2):412-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">7543772</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Hum Pathol. 1986 Dec;17(12):1250-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">3025074</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Gynaecol Oncol. 2012;33(3):257-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22873094</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Clin Pathol. 2008 Aug;130(2):162-4</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18628083</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Low Genit Tract Dis. 2013 Jul;17(3):255-60</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23733162</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Int J Cancer. 2013 May 1;132(9):2087-94</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23065631</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Am J Surg Pathol. 2010 Aug;34(8):1077-87</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20661011</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>JAMA. 2004 May 5;291(17):2100-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15126438</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Expert Rev Proteomics. 2012 Apr;9(2):149-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22462787</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Clin Pathol. 2002 Apr;55(4):244-65</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11919208</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Eur J Gynaecol Oncol. 2003;24(5):373-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">14584647</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Clin Pathol. 2005 Nov 16;5:10</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">16288661</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Mol Diagn. 2012 Jan;14(1):22-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22166544</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
